VANCOUVER, Jan. 16 /PRNewswire-FirstCall/ - Biotech Holdings reports that sales for the quarter ended December 31, 2006 exceeded the combined sales of the first two quarters, ended September 30, 2006, by $55,692 or 73%. The sales during the quarter ended December 31/06, at $127,194, exceeds sales of $99,137 generated during the quarter ended December 31, 2005, and is the second-largest quarterly sales total recorded to date. The Company's interim financial statements, complete with Management Discussion and Analysis for the third quarter, ended December 31, 2006, will be issued in February, 2007, with filing to www.sedar.com, where all prior financial statements together with Management Discussion and Analysis are available.
In addition to the year-over-year sales increase, sales during the December 31/06 quarter itself increased each month, suggesting a trend of sales growth following the Company's resumption of advertising support for the product and the Company's managers taking over the marketing of Sucanon in Mexico in September, 2006.
This release has been approved by the Board of Directors of Biotech Holdings.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
Robert B. Rieveley, Pres.
On behalf of the Board of Directors
Any statements made in this release that are not based on historical fact are forward-looking statements. Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions and may differ materially from what is expressed.
CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 (toll-free), 8 a.m. to 4 p.m. Pacific time; for background information on Biotech Holdings, or to receive news updates, see www.biotechltd.com
Biotech Holdings Ltd.
CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 (toll-free), 8a.m. to 4 p.m. Pacific time; for background information on BiotechHoldings, or to receive news updates, see www.biotechltd.com